HEXA-BETALIN Drug Patent Profile
✉ Email this page to a colleague
When do Hexa-betalin patents expire, and when can generic versions of Hexa-betalin launch?
Hexa-betalin is a drug marketed by Lilly and is included in one NDA.
The generic ingredient in HEXA-BETALIN is pyridoxine hydrochloride. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the pyridoxine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Hexa-betalin
A generic version of HEXA-BETALIN was approved as pyridoxine hydrochloride by FRESENIUS KABI USA on December 31st, 1969.
Summary for HEXA-BETALIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 147 |
Patent Applications: | 3,114 |
Formulation / Manufacturing: | see details |
DailyMed Link: | HEXA-BETALIN at DailyMed |
US Patents and Regulatory Information for HEXA-BETALIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lilly | HEXA-BETALIN | pyridoxine hydrochloride | INJECTABLE;INJECTION | 080854-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |